Skip to main content

Table 4 Markers of severity of disease divided by ceiling of care decisions

From: Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data

  All patients (n = 409) Level 1 (n = 208) Level 2 (n = 75) Level 3 (n = 126) p-value
Laboratory findings
 Hb 129·2 ± 20·7 126·6 ± 21·8 125·0 ± 21·6 135·9 ± 16·5 < 0·001
 WCC 7·0 (5·4–9·4) 7·2 (5·4–10·0) 6·5 (5·0–9·1) 7·1 (5·6–9·5) 0·23
 ANC 5·4 (4·0–8·0) 5·7 (4·0–8·9) 5·1 (3·9–7·8) 5·6 (4·2–8·3) 0·38
 Lymphocyte count 0·8 (0·5–1·1) 0·7 (0·5–1·1) 0·7 (0·5–1·0) 0·8 (0·6–1·1) 0·12
 Na2+ 138 (136–141) 140 (136–145) 137 (135·8–140) 137 (135–139) < 0·001
 K+ 4·0 (3·7–4·4) 4·0 (3·7–4·5) 4·2 (3·7–4·5) 3·9 (3·7–4·2) 0·034
 Creatinine 81 (63–117) 95 (68–143) 86·5 (65·8–129·5) 74 (60·3–89·8) < 0·001
 CRP 90 (45–169) 77·5 (34·8–159·8) 106 (72·3–187·3) 110 (68–192) 0·001
 Ddimer 467 (258·5–1035·3) 496 (266–1978) 671 (387–1042) 373 (223–924) 0·068
 hsTNI 20·5 (8·1–60) 40·0 (17·2–94·3) 25·5 (9·9–70·5) 8·5 (4·6–22·2) < 0·001
 Ferritin 460 (220–982) 365 (143·8–671·5) 510 (261·3–946) 674 (338·5–1458) < 0·001
 Procalcitonin 0·15 (0·08–0·38) 0·17 (0·08–0·52) 0·14 (0·08–0·32) 0·15 (0·09–0·40) 0·60
Clinical observations
 RR (min−1) 22 (18–28) 20 (18–28) 22·5 (20–28) 24 (20–29) 0·026
 O2 saturations (%) 94·5 (89–96) 95 (90–97) 94 (88–96) 94 (89–96) 0·065
 Heart rate (min−1) 90 (76–103) 89 (73–102·8) 89 (79–101·3) 96 (86–108·5) 0·001
 SBP (mmHg) 129·2 ± 23·5 130·4 ± 25·5 131·2 ± 24·4 126·2 ± 18·8 0·21
 Temperature (°C) 37·7 ± 1·1 37·4 ± 1·1 37·7 ± 1·1 38·0 ± 1·0 < 0·001
Chest radiography
 COVID-19 [n(%)] 190 (47·4) 61 (29·6) 40 (55·6) 89 (72·4) < 0·001
 Indeterminate [n(%)] 125 (31·2) 79 (38·2) 22 (30·6) 24 (19·5)
 Non-COVID-19 [n(%)] 86 (21·4) 66 (32·0) 10 (13·9) 10 (8·1)
  1. Hb haemoglobin, WCC white cell count, ANC absolute neutrophil count, Na2+ sodium, K+ potassium, CRP C-reactive protein, hsTNI high-sensitivity troponin-I, RR respiratory rate, O2 oxygen, SBP systolic blood pressure